Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma L39373 Final LCD - Effective August 06, 2023 Jun 30, 2023
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R13 - Effective July 1, 2023 Jun 29, 2023
MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test (L37887) - R6 - Effective June 29, 2023 Jun 29, 2023
Billing and Coding: IUD (Hormone-Eluting) for Endometrial Hyperplasia - CPT 58999 (A55061) - R3 - Effective October 15, 2015 Jun 29, 2023
Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing (A55001) - R17 - Effective July 1, 2023 Jun 29, 2023
Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML) (A55711) - R5 - Effective June 01, 2023 Jun 29, 2023
Billing and Coding: Sacroiliac Joint Injections and Procedures (A59244) - R1 - Effective March 19, 2023 Jun 22, 2023
Billing and Coding: Dental Services (A59447) - Effective January 1, 2023 Jun 21, 2023
Multiple Local Coverage Determinations (LCDs) Finalized - Effective July 30, 2023 Jun 16, 2023
Multiple Proposed LCDs - Published for Review and Comments Jun 15, 2023
MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart Allografts (L38355) Retirement - Effective June 09, 2023 Jun 13, 2023
Billing and Coding: MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart Allografts (A57380) Retirement - Effective June 09, 2023 Jun 13, 2023
Billing and Coding: MolDX: Allomap (A54364) Retirement - Effective June 09, 2023 Jun 13, 2023
MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma - Published for Review and Comments Jun 09, 2023
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® (A54386) - R8 - Effective June 1, 2023 Jun 05, 2023
MolDX: Molecular Diagnostic Tests (MDT) (L35160) - R16 - Effective May 04, 2023 May 17, 2023
Billing and Coding: Complex Drug Administration Coding (A58532) Retirement - Effective April 01, 2023 May 05, 2023
Self-Administered Drug Exclusion List (A53032) - R29 - Effective June 25, 2023 May 05, 2023
Urine Drug Testing - Published for Review and Comments May 04, 2023
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R8 - Effective April 20, 2023 Apr 27, 2023